CRT is an abbreviation with several meanings depending on context. In medicine, it most commonly stands for cardiac resynchronization therapy, a treatment for heart failure, or capillary refill time, a quick bedside test of blood circulation. Outside of healthcare, CRT often refers to cathode ray tube (the technology behind older televisions and monitors) or critical race theory (an academic framework in legal and social studies). This article covers the two medical meanings in detail.
Cardiac Resynchronization Therapy
Cardiac resynchronization therapy is a treatment for people with heart failure whose heart chambers no longer beat in sync. In a healthy heart, the left and right ventricles contract together to pump blood efficiently. In some forms of heart failure, electrical signals travel through the heart unevenly, causing one side to contract before the other. This uncoordinated pumping shuffles blood back and forth between regions instead of pushing it out effectively, reducing the volume of blood ejected with each beat.
CRT corrects this by implanting a specialized pacemaker that sends timed electrical impulses to both ventricles simultaneously. This restores coordinated contraction, improves the heart’s pumping efficiency, and increases the amount of blood the heart delivers with each beat. A pooled analysis of randomized trials found CRT reduced overall death rates by 29% and death from worsening heart failure by 38% compared to medication alone.
Who Qualifies for CRT
Not every heart failure patient benefits from CRT. Current guidelines, updated in 2023, recommend the device for patients who meet a specific profile: a significantly weakened heart (ejection fraction of 35% or below), a particular pattern of delayed electrical conduction called left bundle branch block, a QRS duration of 150 milliseconds or longer on an electrocardiogram, and ongoing symptoms despite optimal medication. In plain terms, the heart needs to be both electrically out of sync and mechanically struggling despite drugs before CRT becomes a strong recommendation.
Some patients outside those strict thresholds may still benefit. Women, for instance, appear to respond well even with slightly shorter QRS durations (120 to 149 milliseconds). Newer guidelines also give a cautious nod to patients with mildly reduced ejection fractions between 36% and 50% if they have the same electrical pattern.
CRT-P vs. CRT-D
There are two versions of the device. A CRT-P is a pacemaker only. It synchronizes the heartbeat but does nothing if the heart suddenly develops a dangerous rhythm. A CRT-D combines the pacemaker with a built-in defibrillator that can deliver a shock to stop life-threatening arrhythmias. In large trials, patients who received a CRT-D had a 19% lower rate of death from any cause compared to those with a CRT-P alone. The choice between the two depends on whether someone also faces a meaningful risk of sudden cardiac arrest.
What the Implantation Involves
The procedure is done under local anesthesia with sedation. A surgeon accesses a vein near the collarbone and threads thin wires (leads) into the heart. One lead goes to the right atrium, another to the right ventricle, and a third is guided through a vein on the heart’s surface to reach the left ventricle. That third lead is the trickiest part. The surgeon injects dye to map the veins around the heart, selects a target vein, and carefully advances the lead into position. All three leads connect to a small generator implanted under the skin below the collarbone.
Challenges during the procedure can include difficulty reaching the ideal vein, high pacing thresholds that make stimulation inefficient, or stimulation of the nerve that controls the diaphragm, which causes uncomfortable hiccups with every heartbeat. Leads can also shift out of position during or after the procedure, sometimes requiring a second intervention.
Why CRT Doesn’t Work for Everyone
Roughly 30 to 40% of patients who receive CRT do not show meaningful improvement in the first six months. This non-response has been partly attributed to suboptimal positioning of the left ventricular lead and less-than-ideal device programming. The heart’s anatomy varies from person to person, and sometimes the target vein simply doesn’t allow ideal lead placement.
There is a silver lining. About 30% of initial non-responders go on to show significant improvement by the 12-month mark, meaning the heart continues to remodel and recover over time even when early results are disappointing. Researchers have tested multi-point pacing, which stimulates the left ventricle from multiple locations, as a way to rescue non-responders, but trials have not shown a clear benefit and the approach drains the battery faster.
Capillary Refill Time: The Other CRT
In emergency and critical care medicine, CRT stands for capillary refill time, a quick physical exam test that checks how well blood is circulating to the extremities. A clinician presses firmly on a fingertip or toenail for about ten seconds until the nail bed turns white, then releases and counts how many seconds it takes for normal color to return. That time, in seconds, is the capillary refill time.
A normal result is under 2 to 3 seconds. Anything longer suggests that blood isn’t reaching the small vessels efficiently, which can signal dehydration, blood loss, or shock. In more advanced stages of shock (classes III and IV), capillary refill is almost always prolonged. It’s a particularly valuable tool in pediatric care, where other signs of poor circulation can be harder to detect. Pediatric resuscitation guidelines specifically use a CRT of 2 seconds or less as a target when treating children in shock, and studies have confirmed that hitting that target correlates with adequate oxygen delivery to vital organs.
The test has limitations. Cold ambient temperatures, nail polish, and dark skin pigmentation can make results harder to interpret. It works best as one piece of a larger picture that includes heart rate, blood pressure, mental alertness, and skin appearance.